EUVIMEDEUVIMED entdecken
Crossref

Modulation of experimental colitis by Enterococcus faecalis, Enterococcus faecium, and Bacillus subtilis: insights from infectious and chemical models

Ajinath Kale, Aayush Kamiya, Dipika Limje, Manoranjan Sharma, Riteshri Soni, Meghrajsinh Jadeja, Onkar Date, Hiren Patel, Jinal Patel, Ashvin Patel, Purvi Vyas, Kasinath Viswanathan und 3 weitere

Archives of Microbiology · 2026-11 · 208 (11)

DOI: 10.1007/s00203-026-05091-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Microbiology, online erschienen am 07.08.2026. Verfasst von Ajinath Kale und 14 weiteren Autor:innen. Beteiligte Einrichtung: Zydus Research Centre, Zydus Lifesciences Limited, Sharkhej-Bavla NH No. 8A, Moraiya, Changodar, Ahmedabad, Gujarat, 382 213, India. Hauptthemen laut MEDLINE: Bacillus subtilis, Enterococcus faecalis, Enterococcus faecium, Colitis. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The roles of Enterococcus faecium (E. faecium), Enterococcus faecalis (E. faecalis), and Bacillus subtilis (B. subtilis) in colitis remain poorly defined, with existing literature presenting inconsistent and often contradictory evidence. This study aimed to elucidate their contributions to inflammatory bowel disease (IBD) using both infectious (non-typhoidal Salmonella enterica serovar Typhimurium, S. typhimurium) and chemical (dextran sulfate sodium, DSS)-induced colitis models. Colitis was induced in C57BL/6 mice via a single oral dose of S. typhimurium (ATCC14028) and/or administration of DSS for seven days. E. faecium (ATCC51559), E. faecalis (ATCC700802), and B. subtilis (MTCC25292) were orally administered. Disease progression was assessed through body weight monitoring, disease activity index (DAI), biochemical assays, and histopathological evaluation of colon tissues. Administration of individual E. faecium strain or E. faecalis strain did not significantly alter disease parameters. However, administered strain of E. faecalis exacerbated colitis severity in the S. typhimurium-induced model. Co-administration of DSS with S. typhimurium resulted in a pronounced aggravation of disease severity, as evidenced by clinical, biochemical, and histological markers. Notably, treatment with B. subtilis showed colitis attenuation, demonstrated by improvements in DAI, colon length, fecal calprotectin levels, and histopathological scores. These disease-modifying effects were associated with decreased colonic expression of pro-inflammatory mediators (CXCL-1, TNF-α, IL-1β) and increased levels of the anti-inflammatory cytokine IL-10. Tested strain of E. faecalis does not induce colitis under steady-state conditions in this model but may aggravate pathogen-induced colitis, whereas E. faecium strain shows no significant effect under the applied experimental conditions. Combined DSS and S. typhimurium exposure induces robust colitis, wherein B. subtilis exhibits potential disease-modifying effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacillus subtilisEnterococcus faecalisEnterococcus faeciumColitisProbioticsAnimalsMice, Inbred C57BLDisease Models, AnimalDextran SulfateMiceSalmonella typhimuriumCytokinesColonInterleukin-1betaMaleTumor Necrosis Factor-alphaFemaleInterleukin-10

Stichwörter der Autor:innen

Bacillus subtilisEnterococcus faecalisEnterococcus faeciumSalmonella typhimuriumColitisInflammation

Substanzen

Dextran SulfateCytokinesInterleukin-1betaTumor Necrosis Factor-alphaInterleukin-10

Autor:innen und Institutionen

  • Zydus Research Centre, Zydus Lifesciences Limited, Sharkhej-Bavla NH No. 8A, Moraiya, Changodar, Ahmedabad, Gujarat, 382 213, India.
  • Zydus Research Centre, Zydus Lifesciences Limited, Sharkhej-Bavla NH No. 8A, Moraiya, Changodar, Ahmedabad, Gujarat, 382 213, India. jogeswarmahapatra@zyduslife.com.

Zitieren

APA

Kale, A., Kamiya, A., Limje, D., Sharma, M., Soni, R., Jadeja, M., Date, O., Patel, H., Patel, J., Patel, A., Vyas, P., Viswanathan, K., Mohapatra, J., Chatterjee, A., & Jain, M. (2026). Modulation of experimental colitis by Enterococcus faecalis, Enterococcus faecium, and Bacillus subtilis: insights from infectious and chemical models. Archives of Microbiology, 208(11). https://doi.org/10.1007/s00203-026-05091-2

Vancouver

Kale A, Kamiya A, Limje D, Sharma M, Soni R, Jadeja M, et al. Modulation of experimental colitis by Enterococcus faecalis, Enterococcus faecium, and Bacillus subtilis: insights from infectious and chemical models. Archives of Microbiology. 2026;208(11). doi:10.1007/s00203-026-05091-2

BibTeX
@article{Kale2026,
  author = {Kale, Ajinath and Kamiya, Aayush and Limje, Dipika and Sharma, Manoranjan and Soni, Riteshri and Jadeja, Meghrajsinh and Date, Onkar and Patel, Hiren and Patel, Jinal and Patel, Ashvin and Vyas, Purvi and Viswanathan, Kasinath and Mohapatra, Jogeswar and Chatterjee, Abhijit and Jain, Mukul},
  title = {Modulation of experimental colitis by Enterococcus faecalis, Enterococcus faecium, and Bacillus subtilis: insights from infectious and chemical models},
  journal = {Archives of Microbiology},
  year = {2026},
  volume = {208},
  number = {11},
  doi = {10.1007/s00203-026-05091-2}
}
Kostenlos starten →